Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,533.17
(
-0.73%
)
US TECH 100
23,388.80
(
-0.56%
)
Dow Jones
45,859.60
(
-0.75%
)
Brent Oil
100.46
(
3.79%
)
Bitcoin
70,275.00
(
-0.88%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

GrthzGd

Send PM Follow Ignore
Followers 15
Posts 1612
Boards Moderated 1
Alias Born 09/07/2010

GrthzGd

Re: north40000 post# 192370

Thursday, 06/11/2015 12:35:30 PM

Thursday, June 11, 2015 12:35:30 PM

Post# of 257275
OCAT had just $3.5M in the till as of March 31st, against a burn rate of ~$8M per quarter. So they are continuing their past practice of continuous stock sales, I assume against some sort of shelf offering, to stay afloat.

If their "pluripotent" stem cells story is that compelling--off of three, apparently successful Phase 1 trials in parallel--do you know why they haven't gone out and floated a large offering?

“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today